Concepedia

Jyoti Gulia

JG

2

Publications

33

Citations

2

H-Index

2017

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Jyoti Gulia is an author at Bristol-Myers Squibb (United States).

Publications per year

2017–2018

2

Publications

2

Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-D-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder

Linda J. Bristow, Jyoti Gulia, Michael R. Weed et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 17 citations · Full text

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

Lawrence R. Marcin, Jayakumar Warrier, Srinivasan Thangathirupathy et al. · ACS Medicinal Chemistry Letters · 2018 · 16 citations · Full text

Rows per page

1–2 of 2